By impairing this complex regulatory physiology, low portal insulin concentrations, documented in children with T1D, result in GH hypersecretion, low circulating levels of IGF-I and IGFBP-3, and high circulating levels of IGFBP-1. The gene discussed is GH1; the disease is type 1 diabetes mellitus.